Role of the plasma contact system in the pathogenesis of experimental anti-GBM glomerulonephritis by Villaro, J. (J.) et al.
Clin. exp. Immunol. (1988) 72, 98-102
Role of the plasma contact system in the pathogenesis
of experimental anti-GBM glomerulonephritis
J. VILLARO, A. SANCHEZ IBARROLA* & A. PURROY Department of Nephrology and
*Laboratory of Immunology, Clinica Universitaria de Navarra, Pamplona, Spain
(Acceptedfor publication 27 October 1987)
SUMMARY
To study the participation of the Hageman factor-related contact system of plasma in the
pathogenesis of glomerulonephritis (GN), an anti-BM GN was induced in a group of 10 normal
Brown Norway rats and another of seven Brown Norway BN/Mai Pfd f rats. The latter strain is
characterized by a congenital deficiency of plasma prekallikrein and of high-molecular weight
kininogen, with lengthening of the activated partial thromboplastin time. In the deficient group, one
animal developed crescents in < 25% ofglomeruli, five in 25-50% and one in 50-75%. In the group of
normal rats, extracapillary proliferation was of greater severity: one animal showed crescents in less
than 25% of glomeruli, two in 50-75% and five in more than 75% of glomeruli. Although in both
groups intense glomerular fibrin deposition was documented, the intensity of these deposits was less
severe in the deficient animals. These data suggest, in the first place, that functional integrity of the
contact system is not a necessary requirement for glomerular fibrinogenesis, other mechanisms being
implicated in this phenomenon. On the other hand, this functional deficit has exerted a protective
effect on crescent formation, which suggests that the contact system can play a role as a mediator of
injury in glomerulonephritis, perhaps through the release of contact system-dependent mediators of
inflammation.
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INTRODUCTION
It has been suggested that the Hageman factor-related contact
system of plasma (CS) could play a role in the pathogenesis of
glomerulonephritis (GN) as a mediator of injury, on the basis of
its inflammatory potential (Cochrane, 1978). Such participation
could take various forms, as has been recently reviewed
(Cochrane & Griffin, 1982; Colman, 1984), of which the most
significant are the activation of the classical pathways of
coagulation and the release of phlogistic substances. In fact,
there already exist some papers which indirectly support this
hypothesis. Studies in vitro have shown that collagen and
glomerular basement membrane (GBM), acting as negatively
charged surfaces, are capable of activating the CS (Niewia-
rowski et al., 1965; Cochrane et al., 1972). An immunologically
mediated lesion at the endothelial level could expose GBM and
lead to activation of the CS. Thus, Hageman factor (HF) and
plasma prekallikrein (PPK) deposits have been detected by
immunofluorescence techniques in the glomerular capillary wall
in patients with different types ofGN (Berger & Yaneva, 1982;
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Yamabe et al., 1984). On the other hand, glomerular fibrino-
genesis is a feature of certain types of GN, although the
mechanisms by which it is produced are poorly understood.
Glomerular fibrin is sometimes associated with crescent forma-
tion and irreversible renal damage. Hypothetically it is easy to
relate glomerular fibrinogenesis with a possible activation of the
CS.
This study is to test the possible role of the CS in the
development ofexperimental GN, and specially its hypothetical
implication in glomerular fibrinogenesis and in the pathogenesis
of determined glomerular lesions such as extracapillary
proliferation with crescent formation. We have therefore deve-
loped an experimental model of anti-GBM GN (aGBM GN) in
a strain of Brown Norway rats characterized by a congenital
deficit of two CS proteins: PPK and high molecular weight
kininogen (HMWK).
Both proteins are essential for an adequate functioning of
this biological system, and their lack determines the absence of
CS activation and of the physiopathological pathways which
depend upon it. This strain of rats was the first described by
Damas & Adam (1980), their findings being confirmed later by
Oh-Ishi et al. (1982), who further characterized the quantitative
deficit of these proteins.
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MATERIAL AND METHODS
Animals
Females of two different strains of rats were used: normal
Brown Norway rats and BN/Mai Pfd f Brown Norway rats,
carriers of a partial congenital deficit of PPK and a total
congenital deficit ofHMWK (Oh-Ishi et al., 1982). The weight
of the animals at the beginning of the experiment was between
80 and 120 g.
Anti-GBM serum
aGBM serum was obtained through repeated immunization of
rabbits with rat glomerular antigen emulsified with Freund's
complete adjuvant, and was decomplemented by heating at
56°C for 30 min and then adsorbed with rat plasma and rat red
cells.
Induction ofaGBM GN
GN was induced by a single intravenous injection of 2 ml of
aGBM serum. In order to accelerate the autologous phase, all
animals were pre-immunized with two 1 mg doses of rabbit IgG
in complete Freund's adjuvant, 30 and 15 days before induction.
Experimental groups
This protocol was applied in two experimental groups: the BNn
group, consisting of 10 normal Brown Norway rats, and the
BNd group, consisting of seven BN/Mai Pfd f rats.
Experimental animals were killed 28 days after induction, or
beforehand if they displayed oliguria, oedemas and tachypnea.
Three samples of renal tissue were obtained. One was fixed in
10% formalin in PBS for light microscopic study. The other two
were frozen in liquid nitrogen and stored at - 70°C for
immunofluorescence and to study cortical fibrinolytic activity
(CFA). A 24-h urine collection was obtained weekly in order to
determine proteinuria and urinary fibrin/fibrinogen degrada-
tion products (FDP).
The control group included six normal and six deficient rats,
matched for sex and weight, untreated with aGBM serum and
not subjected to manipulation. For evaluation of PPK concen-
tration and activated partial thromboplastin time (APTT),
blood samples were taken by open heart puncture, under ether
anaesthesia, using plastic tubes containing 1/10 volume of 3 8%
sodium citrate. The plasma samples were stored at -70°C.
PPK concentration and APTT
APTT was studied according to the method of Proctor &
Rapaport (1961). PPK concentration was determined as des-
cribed by Stormorten et al. (1978), using chromogenic substrate
S-23-2 and a PPK activation containing ellagic acid and
phospholipid, and rich in HMWK and HF (AB Kabi diagnos-
tic, Stockholm, Sweden). PPK concentration is expressed as a
percentage with respect to a pool of plasma from six Brown
Norway normal rats (100%).
Proteinuria and urine FDP
Proteinuria (mg/24 h) was estimated by the trichloroacetic acid
method (Henry, Sobel & Segalove, 1956). Urinary FDP (mg/24
h) was detected according to a variant of the method of
Merskey, Kleiner & Johnson (1966), based on inhibition of
haemagglutination of sheep red blood cells sensitized with rat
plasma, using rabbit anti-rat fibrinogen serum. The sensitivity
of our method was 2-4 pg/ml.
Assessment of the histological preparations
The material obtained for light microscopy studies were stained
with haematoxylin-eosin, PAS and Masson's trichrome stain.
Crescents were defined as the proliferation of at least four
adjacent epithelial cells. According to the percentage of glom-
eruli with such lesions, the following scale was established: 1+,
less than 25%; 2+, 25 to 50%; 3+, 50 to 75%; 4+, more than
75% of glomeruli with crescents.
Assessment of immunofluorescence preparations
Direct immunofluorescence was performed by routine tech-
nique using commercial fluorescein isothiocyanate labelled
(FITC) anti-sera against rat IgG and rabbit IgG (Nordic
Immunological Laboratories, Tilburg, The Netherlands). Anti-
rat fibrinogen FITC serum was prepared in our laboratory by
injecting rabbits with purified rat fibrinogen. The intensity of
rabbit IgG and rat IgG deposits was graded from 0 to 3+.
Evaluation of fibrin-related antigen (FRA) deposits was per-
formed in two complementary ways: using a subjective scale of
intensity from 0 to 4+ and by counting the percentage of
glomeruli with extracapillary FRA deposition over a minimum
of 50 glomeruli per section.
Corticalfibrinolytic activity
CFA was demonstrated using the fibrin slide technique, as
reported by Sinchez Ibarrola, Quazzaz & Naish (1981). For
each experimental animal minimum grading is 0 and maximum
is 12 points. This is a semiquantitative method which determines
the presence of the tissue activator of Plasminogen.
Statistics
The results of the quantitative parameters studied are expressed
as the mean+ standard deviation. The statistical analysis was
done using Student's test and the correlation index (r).
RESULTS
Control group
General data. No significant differences between the animals
of the two different strains were observed. Thus, the results are
discussed as one homogenous group. The mean proteinuria was
insignificant (2 85 +0 91 mg/24 h). In no case were urinary FDP
detected. The average CFA was 5-476 + 0-97 points. Direct
immunofluorescence showed the absence of pathological depo-
sits of rabbit IgG, rat IgG and FRA. In the same way, no
worthwhile anomalies were found in light microscopic study.
Assessment of APTT and PPK concentration. See Table 1.
These two parameters have been analysed in the plasma of
animals from the control group. The mean PPK concentration
in the normal Brown Norway rats was 100-83 + 12 78%, whilst
in the deficient rats the result was 33 33 + 19-36%, the difference
being highly significant (2P<0 001). The APTT in the lot of
normal rats varied between 29 and 32 s (mean 31 + 0-6 s), whilst
in the deficient animals it fluctuated between 35 and 53 s (mean
42-66 + 6-47 s), the difference between the means being highly
significant (2P<0-001).
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Table 1. Plasma prekallikrein concentration and acti-
vated partial thromboplastin time in normal and deficient
rats from the control group
% of plasma APTT
prekallikrein (seconds)
Control BNn-l 90 8 32
Control BNn-2 103 32
Control BNn-3 119-4 29
Control BNn-4 82 6 31
Control BNn-5 106 2 32
Control BNn-6 103 31
x~ 100-83 31-16
s.d. 12-78 1-17
Control BNd-l 16-5 45
Control BNd-2 59-1 37
Control BNd-3 43 38
Control BNd-4 15-4 53
Control BNd-5 17 46
Control BNd-6 49 37
x 33-33 42-66
s.d. 19 36 6-47
2P<0 001 2P<0 001
BNn group
Of the 10 animals in the group, two died before the experiment
was completed, it not being possible to gather material for
study. Another four rats were killed (three on the 14th day and
one on the 21st day), as they showed oliguria, oedemas and
tachypnea. Significant proteinuria was found from the 7th day,
reaching a maximum on the 14th day (251 + 30 05 mg/24 h) and
slightly decreasing until day 28 (180-8 + 32 8 mg/24 h). Likewise,
by day 7, a quantifiable elimination of urine FDP was observed
(1 32+0 74 mg/24 h), which increased, reaching a maximum
value of 4 55 + 2 57 mg/24 h on day 28 (Tables 2 and 3).
Direct immunofluorescence showed intense linear deposits
(3 +) of rabbit IgG and rat IgG in all animals. Likewise, in all
sections studied, intense glomerular ARF deposits were
detected, predominantly in extracapillary localization, affecting
an average of94 + 11-9% of glomeruli with an intensity of4+ in
Table 2. Weekly proteinuria in experimental groups (mg/24 h)
Days
7 14 21 28
BNn
n 10 8 5 4
x 200 54 251-87 198-29 180 8
s.d. 33 41 30 05 33 54 32 8
BNd
n 5 7 7 7
xc 305 76 217 63 192 85 185 17
s.d. 48-24 40-55 2274 40 34
t 4.979 2 958 0 336 0-184
2P<0 001 2P<0 01 NS NS
Table 3. Weekly urine-FDP in experimental groups (mg/24 h)
Days
7 14 21 28
BNn
n 10 8 5 4
x 1-32 4-25 3-2 4 55
s.d. 074 221 095 257
BNd
n 5 7 7 7
x 17-74 13-05 15-79 6
s.d. 8-13 6 61 5-27 3-63
6-667 2-286 5-209 0-697
2P<0 001 2P<0 05 2P<0 00l NS
six cases and of 3+ in the remaining two cases (Table 4). It must
be emphasized that the intensity of the glomerular ARF
deposits in the animals killed before the end of the experiment
was similar to that of those killed on day 28.
In all the animals of this group a marked increase in CFA
(average grading 11 -62+ 0 99 points) was shown with respect to
the control group (2P< 0-00 1). The four rats killed beforehand
had the maximum score (Table 4).
BNn group has uniformly developed a severe extracapillary
proliferative GN with a great number of crescents: 4+ in five
cases and 3+ in another two. Only BNn rat 5 showed lesions of
minor intensity (1+). In the same way, the animals killed
beforehand had glomerular lesions of similar severity to the rest
of the group (Table 4).
BNd group
In this group, proteinuria reached its maximum on day 7
(305 + 48-4 mg/24 h), decreasing slightly until day 28
Table 4. BNn group: immunofluorescence, cortical fibrinolytic





























































x 94 11 62
s.d. 11.9 099
SI, subjective intensity of FRA deposits; %ExFRA, percent-
age ofglomeruli with extracapillary FRA; LM, light microscopy.
* Animals killed on day 14.
t Animal killed on day 21.
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SI, subjective intensity of
age ofglomeruli with extracal
summary (Table 2), both groups the components of this biological system essential for its
iria throughout the experiment. On activation. We have been able to show the low concentration of
i of BNd group was significantly PPK in the animals used in this work, as has been previously
i group (2P< 0001), whilst on the reported in the literature (Oh-Ishi et al., 1982). Besides, our rats
group which showed the greater showed an increase in APTT compared with normal Brown
urinary elimination of FDP was Norway control rats. This parameter had not been checked
group, reaching a maximum of before in this strain of rats.
7 and decreasing slightly until day Our aim was to focus on the problem of glomerular fibrin
er than in the BNn group on day 7 deposition and extracapillary proliferation, because ofthe many
05) and day 21 (2P < 0-001) (Table unsolved problems in this field. The interrelationship between
several biological systems (contact system, coagulation, fibrino-
nce studies showed intense linear lysis, kinins, etc; Cochrane, 1978; Cochrane & Griffin, 1982)
rand rat IgG in all animals, in the could play a role in the mechanisms leading to glomerular fibrin
I. Likewise, in all sections studied deposition. Besides these interactions could be responsible for
of FRA were detected, predomin- the glomerular fibrinolytic response and be significant in the
ition. They involved a mean of modulation of the inflammatory process.
an intensity of 4 + in two cases and Up to now, several pieces of indirect evidence have consi-
dered the participation of the CS in the pathogenesis of
id group have shown an important glomerulonephritis. Berger & Yaneva (1982) detected glomeru-
3 point) with respect to the control lar deposits of HF and PPK in patients with membranous GN,
vas no statistical difference within suggesting the implication of the CS in the alteration of
glomerular permeability. Yamabe et al. (1984), showed depo-
group also showed extracapillary sition of HF both in the capillary wall and the glomerular
rescent formation: I + in one rat, mesangium in patients with IgA nephropathy. In an experimen-
able 5). In summary, although the tal model of aGBM GN in dogs (Nakamura, Kazama & Be,
ise extracapillary proliferative GN, 1979) a decrease of PPK concentration with elongation of
tion was considerably more signifi- APTT has been demonstrated. These authors implicated the CS
in the pathogenesis of GN.
In this paper, we have induced an accelerated model of
e proteinuria and urine FDP severe glomerulonephritis characterized by the presence of
as found a statistically significant extracapillary proliferation and the deposition of glomerular
the two parameters observed fibrin. These two features are present in the animals deficient in
iment. proteins of the CS, and this fact becomes a new argument
against the implication of an unique thrombin-dependent
CUSSION mechanism in the generation of glomerular fibrin (Bone et al.,
1975; Border, Wilson & Dixon, 1975).
However, when the deficient animals are compared with
GBM GN looks adequate because normal BN rats, some striking differences appear. The animals
ciency of these animals in some of with an impaired contact system develop a less severe GN, with
a minor degree of extracapillary proliferation and glomerular
nofluorescence, cortical fibrinolytic fibrin deposition. We think these data can be taken as evidence
f crescents on light microscopy for a role of the contact system in the pathogenesis of this
experimental model because of the protective effect afforded by
the deficiency of components of such biological system shown in
this paper. Such protection could be exerted through the lack of
FRA contact system dependent mediators of inflammation in the BN
deficient rats.
SI %ExFRA CFA LM Considering protein excretion in these animals the picture
looks different. The protection afforded in the CS deficient
3+ 92 12 2+ animals when we look at the histological glomerular damage is
3+ 84 1 1 2+ not present when the alteration of glomerular permeability is
3 + 94 1 1 2 + considered. It is worth emphasizing that structural damage and
4 + 94 1 1 3+ protein excretion are not related parameters as demonstrated in4+ 90 12 2+ human glomerulonephritis. However the correlation between
4 + 92 12 2++ glomerular structural damage and the best index of glomerularfunction, i.e. glomerular filtration, seems to be present in our
x 91 14 11-62 study. In this sense we can speak of protection in the BNd rats
s.d. 3-43 0-53 bearing in mind that several of the animals in the BNn group
died before the end of the experiment, probably of renal failure,
ERA deposits; %ExFRA, percent- although we have no biochemical data to confirm this possibi-
pillary FRA; LM, light microscopy. lity. The different evolution of proteinuria between the normal
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and the deficient groups of rats cannot be explained with the
data which are available in this study. Perhaps minor histologi-
cal damage from the beginning could allow a higher protein
excretion as occurred in day 7 in the BNd animals.
These deficient animals showed an increased tissue fibrinoly-
tic response as well as a higher excretion of urinary FDP and a
lesser deposition of glomerular fibrin when compared with the
normal BNn group. Perhaps minor inflammatory damage at the
endothelial level in the deficient group, because of the lack of
mediators, could be responsible for a better fibrinolytic response
and, thereby for more efficient fibrin clearance and higher
excretion of FDP in urine. The method used here to assess the
tissue fibrinolytic response, being semi-quantitiative, is not
sufficient to demonstrate this possibility.
The lack of correlation between the elimination of proteins
and FDP in urine speaks clearly in favour of fibrinolytic
mechanisms in the clearance of glomerular fibrin, at least in this
experimental model.
In summary, the data presented in this paper, together with
other information previously reported support a pathogenetic
role for the contact system in the development ofimmunological
glomerulonephritis.
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